ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Jaguar Health Inc

Jaguar Health Inc (JAGX)

10.91
2.85
(35.36%)
Cerrado 26 Abril 3:00PM
10.85
-0.06
(-0.55%)
Fuera de horario: 6:59PM

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
10.85
Postura de Compra
10.75
Postura de Venta
11.17
Volume Operado de la Acción
2,979,568
8.22 Rango del Día 15.48
0.196 Rango de 52 semanas 21.60
Capitalización de Mercado [m]
Precio Anterior
8.06
Precio de Apertura
8.22
Última hora de negociación
Volumen financiero
US$ 34,115,395
Precio Promedio Ponderado
11.4498
Volumen promedio (3 m)
354,707
Acciones en circulación
674,043
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.19
Beneficio por acción (BPA)
-57.11
turnover
11.69M
Beneficio neto
-38.49M

Acerca de Jaguar Health Inc

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class ant... Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Jaguar Health Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker JAGX. The last closing price for Jaguar Health was US$8.06. Over the last year, Jaguar Health shares have traded in a share price range of US$ 0.196 to US$ 21.60.

Jaguar Health currently has 674,043 shares in issue. The market capitalisation of Jaguar Health is US$5.43 million. Jaguar Health has a price to earnings ratio (PE ratio) of -0.19.

JAGX Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
15.2593.755.611.265.52491856.91122273CS
45.52103.5647279555.3311.264.02683755.40186669CS
129.951105.555555560.911.260.1963547070.8883051CS
269.73868.751.1211.260.1963938950.96642665CS
521.05210.73688507869.79821.60.196506720214.15684245CS
156-2203.15-99.50993676622142260.80.1969084564114.79479607CS
260-1969.15-99.452020202198020113.20.196105133863377.54507025CS

JAGX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Jaguar Health?
El precio actual de las acciones de Jaguar Health es US$ 10.85
¿Cuántas acciones de Jaguar Health están en circulación?
Jaguar Health tiene 674,043 acciones en circulación
¿Cuál es la capitalización de mercado de Jaguar Health?
La capitalización de mercado de Jaguar Health es USD 5.43M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Jaguar Health?
Jaguar Health ha negociado en un rango de US$ 0.196 a US$ 21.60 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Jaguar Health?
El ratio precio/beneficio de Jaguar Health es -0.19
¿Cuál es el ratio de efectivo a ventas de Jaguar Health?
El ratio de efectivo a ventas de Jaguar Health es 0.63
¿Cuál es la moneda de reporte de Jaguar Health?
Jaguar Health presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Jaguar Health?
El último ingresos anual de Jaguar Health es USD 11.69M
¿Cuál es el último beneficio anual de Jaguar Health?
El último beneficio anual de Jaguar Health es USD -38.49M
¿Cuál es la dirección registrada de Jaguar Health?
La dirección registrada de Jaguar Health es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Jaguar Health?
La dirección del sitio web de Jaguar Health es jaguar.health
¿En qué sector industrial opera Jaguar Health?
Jaguar Health opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WWWW International Inc
US$ 0.395
(167.62%)
223.58M
OMEXOdyssey Marine Exploration Inc
US$ 1.4979
(75.79%)
285.65M
RTCBaijiayun Group Ltd
US$ 0.3244
(74.88%)
263.23M
GREEGreenidge Generation Holdings Inc
US$ 1.3197
(53.92%)
5.84M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.28
(44.30%)
38.04M
CGTLCreative Global Technology Holdings Ltd
US$ 1.5197
(-75.09%)
3.88M
TOIIWOncology Institute Inc
US$ 0.1015
(-40.22%)
156.14k
COEPCoeptis Therapeutics Holdings Inc
US$ 7.70
(-38.25%)
716.99k
INTSIntesity Therapeutics Inc
US$ 0.56
(-37.78%)
3.21M
SMMTSummit Therapeutics Inc
US$ 23.47
(-36.05%)
24.67M
GNLNGreenlane Holdings Inc
US$ 0.012699
(-15.34%)
355.22M
AGMHAGM Group Holdings Inc
US$ 0.0477
(22.31%)
340.91M
OMEXOdyssey Marine Exploration Inc
US$ 1.4979
(75.79%)
285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.455
(19.62%)
266.95M
RTCBaijiayun Group Ltd
US$ 0.3244
(74.88%)
263.23M

JAGX Discussion

Ver más
zendeli1 zendeli1 2 horas hace
But now Jaguar Health currently has just 674 K shares outstanding🚀🚀🚀
👍️ 1
SmellMyFinger SmellMyFinger 3 semanas hace
Sorry to hear that. The reverse/splits are an abomination and never seem to bring anything worthwhile to bulls.
👍️0
Stino2 Stino2 1 mes hace
76484$ I have put in this scam, everytime a new RS 🤮and now I have 999$ left, I will keep them till OOOOOOOO$
👍️ 1 😢 1
Renee Renee 1 mes hace
JAGX: effective March 24,2025 a one for 25 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
MyDogBailey MyDogBailey 1 mes hace
This management is abysmal and embarrassing. Not even a PR to explain this, just hiding behind an 8k. Don't give a crap about their shareholders. And their Board is ok with this?
👍️0
DTGoody DTGoody 1 mes hace
It's crazy
👍️0
MD3 MD3 1 mes hace
This one and $MULN love to RS every few months
👍️0
oldstocks oldstocks 1 mes hace
Series J Preferred Stock? Are these getting reverse split too?

Series J Preferred Stock is not entitled to vote, on an as-converted basis and in the aggregate with respect to any shares of Common Stock and preferred stock of the Company beneficially owned by such holder and any Affiliates or Attribution Parties (as such terms are defined in the Certificate of Designation of Series J Preferred Stock) of such holder, more than 9.99% of the Company’s outstanding shares of Common Stock as of the applicable record date.

The final results for the votes regarding each proposal are set forth below.

1.
Proposal to approve an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding voting common stock, par value $0.0001 per share, at a ratio of not less than 1-for-15 and not greater than 1-for-40, with the exact ratio, if approved and effected at all, to be set within that range at the discretion of the Company’s board of directors and publicly announced by the Company on or before March 13, 2026 without further approval or authorization of the Company’s stockholders, was approved by the stockholders by the following vote:
👍️0
DTGoody DTGoody 1 mes hace
You can definitely make money if you can time this one right. Most of the time you will just get your nuts caught if you trade JAGX. I never seen a company dilute and then reverse split like this company does. This has to be one of the worst offenders.
👍️0
oldstocks oldstocks 1 mes hace
DT you not jumping in on JAGX?
I don’t blame you.
In the past when i was losing a lot of money on this stock i loaded up heavily when it got to cheap and i pulled out with a nice profit.
It was a gamble but i don’t think i would do it again
👍️0
DTGoody DTGoody 1 mes hace
I don't know who in their right mind would want to invest in this company unless they like losing money. Just unbelievable!
👍️0
MyDogBailey MyDogBailey 1 mes hace
Did I read that right? Another stock split???
👍️0
GetSeriousOK GetSeriousOK 2 meses hace
I hate to say this, but the "Shareholder Rights Plan" sounds like a complete load of bullshit.

Maybe I'm missing something.
👍️0
SmellMyFinger SmellMyFinger 2 meses hace
Fair question and accurate observation.
👍️0
GetSeriousOK GetSeriousOK 2 meses hace
Conte can expect the NASD 30-day deficiency notice this week. That gives her a year to play the NASD "request an extension" game before another reverse split.

I like to gamble on zombie biotechs that fail a P3 or get an FDA rejection and get hammered even though they have a drug or device that works. This one is interesting. No illusions on my part..... just starting DD and weighing the risk vs reward.

They'll get a journal publication for Crofelemer and breast cancer, IMO, but cherry-picking a failed P3 rarely convinces the FDA to approve a drug. I'm wondering about plans for another trial? Anyone know?
👍️0
EmperorVoyager30 EmperorVoyager30 4 meses hace
all information was available in the poster presentation in San Antonio, where I attended :) take care bears
👍️0
EmperorVoyager30 EmperorVoyager30 4 meses hace
onset and sustained efficacy

a larger portion of patients with breast cancer receiving crofolemer were responders for all 3 months
p value long term = 0.0123
that means 💲
👍️0
EmperorVoyager30 EmperorVoyager30 4 meses hace
patients with breast cancer showed significant improvement with crofolemer over placebo
p value = 0.0245

In a drug trial, a "good" p-value is generally considered to be less than 0.05; this means that there is less than a 5% chance that the observed results occurred by random chance, indicating a statistically significant difference between the drug and the control group.
👍️0
ATM123 ATM123 4 meses hace
Will this pos ever make some money for the share holders...so many pr's making no difference
👍️0
SmellMyFinger SmellMyFinger 4 meses hace
This stock has been a bane to me.
👍️0
ATM123 ATM123 4 meses hace
No news about the partnership at the conference or after the conference....
👍️0
MyDogBailey MyDogBailey 4 meses hace
Up 30% on 2m volume, any idea what's cookin?
👍️0
SmellMyFinger SmellMyFinger 6 meses hace
This stock really got hammered the past few years.
👍️0
timberwolf7 timberwolf7 7 meses hace
Suspect its on a 'life support' device
hidden in a locked room.

With a couple of folks still around
with a mission of trying to figure out
how to keep the plug from being pulled.

Disclaimer: did get out with some 'gains' cause
I sold out before the news hit. And only reason
for dropping 'in' was cause I was curious to see what
was being said (and I haven't deleted the board cause
I am curious to see if they will be able to take another
run at it)
👍️0
MyDogBailey MyDogBailey 7 meses hace
Is this thing dead now?
👍️0
SmellMyFinger SmellMyFinger 8 meses hace
The market conditions are rough right now pending political events.
👍️0
Monksdream Monksdream 8 meses hace
JAGX new 52=week low
👍️0
ShadowDiviner72 ShadowDiviner72 9 meses hace
That's why I chose to exit my position for now
👍️0
Tom turtles Tom turtles 9 meses hace
Fuc k November...and F uck Conte
👍️0
ShadowDiviner72 ShadowDiviner72 9 meses hace
I think data was as expected. Look, cancer patients on TARGETED therapies have a 95% chance of getting CID. Breast and Lung cancer patients in ONTARGET received TARGETED therapies. So, if it worked on 75% of the patients. Which is the group were 95% of the patients get CID, the trial is succesfull... simple.

HOWEVER, I exited my position for the following reason: In my opinion there was not shared any detailed information, because the principal investigator wants to take the data to SABCS (breast cancer symposium), like they did with the phase 2 trial.

I've seen it with other stocks that the principal investigators prefere this. And they decide where data is presented. So in my opinion we can wait for the full data till december 9th (SABCS)

So, unless the POC data for SBS and MVIS shows up, or a a new partnership... it will be a long wait, and shorts will take it down again. That's why I chose to exit, but I will be back in november
👍️ 1
powerbattles powerbattles 9 meses hace
Scam POS over 20 years endless printing shares and r/s.
👍️0
Serge521 Serge521 9 meses hace
WOW I was close to jump on this a few days ago...I ned a break trading these loser pennies
👍️0
Risk Risk 9 meses hace
What your plan Shadow? You are/were a big supporter, do you think the data is good? Any chances of recovery or it’s just another ?
👍️0
MyDogBailey MyDogBailey 9 meses hace
This CEO needs to be investigated. The RS was BS, the "imminent" publishing of data??? These have totally screwed the shareholder, and she damn well knew exactly what was happening, or this thing would have been sub penny.
👍️0
moneydreamer moneydreamer 9 meses hace
For sure not a good stock at all unless around 5 cents then I can play with it. Free ATM for the CEO all they do offering dumping and RS
👍️0
ShadowDiviner72 ShadowDiviner72 9 meses hace
I was owning shares. 75% down.

Data was GOOD, as I predicted. Can't blame my own DD

Can blame management. Wtf was that for a shit show. No complete data, horrible press release. Horrible managed
👍️0
Tom turtles Tom turtles 9 meses hace
I really don't think Shadow ever owned any shares. He was just here to spout lies about the results and try to get the last drop of money out of the remaining unsuspected shareholders....koddos to you shadow. Great job. This will be back to 5 cents again in no time... Another offering , another reverse split maybe they'll change their name to TIGX... Same criminals , same outcome. CEO waited till now because she's leaving for her European trip and Africa trip tomorrow. She just wanted to get the frig out of Dodge before the death threats started.
👍️0
hole-in-one hole-in-one 9 meses hace
Me too. They try and BS everyone with the “we have to do this to stay in the nasdaq”. That kills the shareholder especially when like you said, it will be at a nickel again soon. Glad I got out as soon as I heard anything about a reverse split and how good it was going to be for the company and shareholders. Not even good for the company because no one has faith or trust in the controlling interests anymore.
👍️0
peterus peterus 9 meses hace
lol idiot
👍️0
peterus peterus 9 meses hace
right lol .... big redddddd
👍️0
peterus peterus 9 meses hace
right lol .....
👍️0
peterus peterus 9 meses hace
mr brains how is your account????
i knowwww biggggg redddddd
👍️0
peterus peterus 9 meses hace
look at the pps i told you idiots
👍️0
Monksdream Monksdream 9 meses hace
JAGX new 52 week low
👍️0
moneydreamer moneydreamer 9 meses hace
So happy I got out before RS this junk one so dead years ago but I will buy some when it drops to 5 cents which it’s coming soon
👍️0
Awl416 Awl416 9 meses hace
Mayday!!!!
👍️0
DTGoody DTGoody 9 meses hace
Yes, after the next reverse split! LOL
👍️0
DTGoody DTGoody 9 meses hace
Yes, after the next reverse split! LOL
👍️0
DTGoody DTGoody 9 meses hace
I got out while I was ahead pre-split, and she is Definitely Not My CEO!!! LOL You must have me confused with someone else???

With that said I was really hoping for the ones who went through the reverse split here could have gotten paid and not had their cakes taken by this CEO Twice!
👍️ 1
Serge521 Serge521 9 meses hace
Do you still see 10$ coming??
👍️0

Su Consulta Reciente

Delayed Upgrade Clock